Stocks
NanoViricides, Inc.NNVC
AMEXHealthcareBiotechnology$1.18+1.90%
Focused on developing nanomedicine-based antiviral therapies, this biopharmaceutical company specializes in treatments for viral diseases including influenza, HIV, and herpes. Investors monitor its progress due to its novel platform technology and pipeline targeting high-need viral infections with limited treatment options.
Market Cap: $21.1M52W Range: $0.85 – $2.23
Congressional Interest in NanoViricides, Inc. (NNVC)
1 member of Congress has disclosed 1 trade in NanoViricides, Inc. (NNVC), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading NNVC?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-04-07 | Kelly Loeffler | sell | $1K – $15K |